Laboratorios Silanes S.A. de C.V.: all 55 studies

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout ArthritisRecruitingNCT06863701Phase 3
• A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab,CompletedNCT00868309Phase 2Results posted
• Black Widow Spider Antivenin for Patients With Systemic LatrodectismCompletedNCT00657540Phase 3Results posted
• Comparative Bioavailability Study Between Etoricoxib / Betamethasone Administered Individually or in CombinationCompletedNCT07454369Phase 1
• Comparative Bioavailability Study Between Ticagrelor and ASA Administered Individually or in Combination.CompletedNCT07444164Phase 1
• Efficacy and Safety of Etoricoxib/Betamethasone Combination in Acute Bursitis, Tendinitis and SynovitisCompletedNCT07328022Phase 3
• Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus DesloratadineCompletedNCT06916884Phase 3
• Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle SpasmCompletedNCT06863662Phase 3
• Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute ExacerbationCompletedNCT06863636Phase 3
• Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus LoratadineCompletedNCT06531707Phase 3
• Efficacy and Safety of Etoricoxib/Cyanocobalamin Versus Etoricoxib for Acute Low Back PainCompletedNCT06517823Phase 3
• Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic PainCompletedNCT06516094Phase 3
• Comparative Bioavailability Study Between Etoricoxib and Tramadol, Administered Individually or in CombinationCompletedNCT05533073Phase 1
• Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen, Tablets Administered Individually or in CombinationCompletedNCT05428306Phase 1
• Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen Oral SuspensionCompletedNCT05428293Phase 1
• Non-interaction Study Between Pregabalin and Tramadol, Administered Individually or Combination, in Healthy SubjectsCompletedNCT05389150Phase 1
• Efficacy and Safety of Pregabalin/Tramadol Combination Versus Pregabalin in Acute Pain of Neuropathic OriginCompletedNCT05324059Phase 3
• Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of ScalpCompletedNCT05105139
• Non-interaction Study of Chlorthalidone and Losartan in Fixed Combination, in Healthy Subjects, Under Fasting ConditionsCompletedNCT05090449Phase 1
• Comparison of Bioavailability of Dexketoprofen-Vit B vs Dexketoprofen, in Healthy Subjects, Under Fasting ConditionsCompletedNCT05027126Phase 1
• Efficacy and Safety of Dexketoprofen/Vitamin B Vs Dexketoprofen for Post-traumatic Cervical Sprain Grade I-IICompletedNCT05001555Phase 3
• Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back PainCompletedNCT04968158Phase 3
• Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 DiabetesSuspendedNCT04943692Phase 3
• Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial HypertensionCompletedNCT04927299Phase 3
• Safety of doTBal® in Patients With Tuberculosis: Conduction of an Intensive Pharmacovigilance ProgramCompletedNCT04916899
• Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual ComponentsCompletedNCT04895059Phase 1
• Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.Status unknownNCT04882293Phase 3
• Study to Evaluate the Safety of the Fixed-dose Combination Rosuvastatin/Ezetimibe for Patients With DyslipidaemiaCompletedNCT04862962
• Pharmacokinetic Study Protocol of ANAWIDOW Lyophilized Powder for Solution for Intravenous Use in Fasting ConditionsCompletedNCT04848714Phase 1
• Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment FailureCompletedNCT04841096Phase 3
• Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2WithdrawnNCT04626089Phase 2
• Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.CompletedNCT04625985Phase 2
• Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and ObesitySuspendedNCT03051451Phase 2
• Efficacy Study of Metformin Glycinate on Postprandial LipemiaStatus unknownNCT02064881Phase 2/3
• Metformin vs Conjugated Linoleic Acid and an Intervention Program With Healthy Habits in Obese ChildrenStatus unknownNCT02063802Phase 2
• Open Label Clinical Trial of Anascorp® in Pediatric Patients With Scorpion Sting EnvenomationCompletedNCT01599936Phase 3
• Open Label Study of Alacramyn® in Pediatric Patients With Scorpion Sting EnvenomationCompletedNCT01599923Phase 3
• Clinical Trial to Evaluate Safety and pK Profile of Metformin Glycinate in Healthy VolunteersCompletedNCT01560481Phase 1
• BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet StudyCompletedNCT01437813Phase 1
• BIOAVAILABILITY OF GLI/METXR (4/850 mg)CompletedNCT01437800Phase 1
• Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes PatientsCompletedNCT01429818Phase 4
• Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 DiabetesCompletedNCT01386671Phase 3
• A Trial of Equine F (ab')2 Antivenom for Treatment of Scorpion Envenomation in MoroccoCompletedNCT01336660Phase 2/3
• Gastric Tolerability and Pharmacokinetics of DMMET-01CompletedNCT00960882Phase 1
• Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese PatientsStatus unknownNCT00941382Phase 3
• Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)CompletedNCT00941239Phase 1
• Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes MellitusCompletedNCT00941161Phase 4
• Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)CompletedNCT00940797Phase 2
• Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes PatientsCompletedNCT00940472Phase 2/3
• Establishment of Natural History of Scorpion EnvenomationCompletedNCT00696683
• Double-Blind, Alacramyn® vs. Placebo in Pediatric PatientsCompletedNCT00685230Phase 2/3
• Study to Evaluate the Efficacy of Two Treatment Schemes With Antivipmyn ® for the Treatment of Snake Bite EnvenomationTerminatedNCT00639951Phase 4
• Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip.CompletedNCT00636116Phase 3
• Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting EnvenomationCompletedNCT00624078Phase 2/3
• The Efficacy and Safety of Aracmyn in Patients With Systemic LatrodectismCompletedNCT00247078Phase 2

← Laboratorios Silanes S.A. de C.V. overview and focus areas